CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Head & Neck Cancer

ONCOLOGY. Vol. 13 No. 5
Pages: 1  2  
Next
 

Current Imaging Techniques for Head and Neck Tumors

By Jane l. Weissman, MD1, Raucheline Akindele, MD2 | May 1, 1999
1Deparment of Head and Neck Imaging 2Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

ABSTRACT: Modern head and neck imaging has led to advances in both the diagnosis and treatment of head and neck cancers. Both computed tomography (CT) and magnetic resonance imaging (MRI) studies provide important information about the location and extent of neoplasm, particularly with respect to the interface of tumor with bone, fat, muscles and other soft tissues, air, blood vessels, dura, and brain. Conventional angiography can be used to assess tumor blood supply and vascularity and to perform therapeutic embolization. Magnetic resonance angiography (MRA) and CT angiography (CTA) are new tools for the noninvasive evaluation of blood vessels. Positron emission tomography (PET) shows promise for differentiating tumor from scar, edema, and other nonneoplastic soft tissues. [ONCOLOGY 13(5):697-709, 1999]

Introduction

FIGURE 1
Arteriogram of the common carotid Arteriogram of the common carotid

Modern head and neck imaging has advanced both the diagnosis and treatment of head and neck neoplasms. Computed tomography (CT) and magnetic resonance imaging (MRI) studies assess the interface of tumor with bone, fat, muscles and other soft tissues, air, blood vessels, dura, and brain. Conventional catheter angiography provides an assessment of tumor blood supply and vascularity, and at angiography, therapeutic embolization can also be performed. Magnetic resonance angio- graphy (MRA) and the newer CT angiography (CTA) provide tools for the noninvasive evaluation of blood vessels. Positron emission tomography (PET) scanning is just beginning to make contributions to the field of head and neck tumor imaging.

Tumor

FIGURE 2A
Computed tomography shows dense, chronically obstructed secretions in the left sphenoid air cell (S). The enhancing tumor in the nasal cavity (open arrow) is only slightly more dense than the obstructed secretions, making it difficult to know where tumor ends and dense obstructed secretions begin. The contents of the right sphenoid air cell have a lower density (R), suggesting more watery secretions. Computed tomography shows dense, chronically obstructed secretions in the left sphenoid air cell (S). The enhancing tumor in the nasal cavity (open arrow) is only slightly more dense than the obstructed secretions, making it difficult to know where tumor ends and dense obstructed secretions begin. The contents of the right sphenoid air cell have a lower density (R), suggesting more watery secretions.
FIGURE 2B
T1-weighted MRI shows hyperintense proteinaceous secretions of the left sphenoid air cell (black arrow); the appearance was the same before gadolinium administration. The right air cell contents (white arrow) are hypointense, which indicates that the protein content is lower and water content is greater than that of the left air cell. The tumor (t) in the nasal cavity enhances intensely. T1-weighted MRI shows hyperintense proteinaceous secretions of the left sphenoid air cell (black arrow); the appearance was the same before gadolinium administration. The right air cell contents (white arrow) are hypointense, which indicates that the protein content is lower and water content is greater than that of the left air cell. The tumor (t) in the nasal cavity enhances intensely.
(MORE: Commentary (Lanzieri): Current Imaging Techniques for Head and Neck Tumors)

On CT without intravenous contrast, tumor is usually of intermediate density.[1,2] Tumor, blood vessels, muscles, and lymph nodes may all have the same density.

After the intravenous (IV) administration of iodinated contrast medium, tumors enhance to varying degrees: Paragangliomas, being very vascular, enhance intensely, whereas squamous cell carcinomas, being more cellular, may enhance intensely, or little or not at all. Foci of necrosis or prior hemorrhage are dark (hypodense) on CT. Lacking a blood supply, necrotic foci do not enhance after contrast administration.

On MRI, tumor signal is quite variable. Many head and neck neoplasms are isointense to (ie, have the same signal as) soft tissues (brain, muscle) on nonenhanced T1-weighted images, are isointense to hyperintense (have the same or brighter signal) on T2-weighted images, and enhance at least somewhat after IV gadolinium.[1] Very cellular or fibrous neoplasms that contain little free water may be hypointense (dark) on T2-weighted image.[1,3] Necrosis produces a fluid signal on MRI; this is hypointense on T1-weighted images and hyperintense on T2-weighted images. As on CT, necrotic foci do not enhance on MRI images after contrast administration.

Some tumors have a distinctive appearance that allows a histologic diagnosis to be made (or suggested) on the basis of the preoperative imaging studies. This is usually based on a combination of factors, such as location, enhancement, and effect on adjacent structures. For example, a carotid body tumor arises at the carotid bifurcation (Figure 1) and enhances intensely on CT and MR studies. An esthesioneuroblastoma (olfactory neuroblastoma) involves the upper nasal cavity, anterior cranial fossa, and adjacent sphenoid and ethmoid sinuses (Figure 2a and Figure 2b).

FIGURE 3
Calcifications Calcifications

Calcifications within a tumor are white on CT (Figure 3) and usually a signal void (black) on MRI. These may represent residual normal bone or tumor matrix. Calcified tumor matrix suggests a bone- or cartilage-forming tumor, such as a chondrosarcoma.

Most often, however, the importance of imaging is the accurate delineation of the extent of the tumor. This includes identifying structures that are spared by the tumor, as well as structures that are affected.

Muscles and Other Soft Tissues

Tumor and muscle (sclera, mucosa) may have similar appearances on both CT and MRI studies (Figure 4). Tumor usually enhances more than any structures, except mucosa and the extraocular muscles. These muscles, unlike other skeletal muscles, enhance intensely on MRI studies (Figure 5). Interestingly, the enhancement is not apparent on CT images.

Fibrous Tissue

FIGURE 4
Tumor vs Muscle on CT Tumor vs Muscle on CT
FIGURE 5
Tumor vs Muscle on MRI Tumor vs Muscle on MRI

Scar tissue has a variety of appearances, depending on its age. Granulation tissue enhances intensely; fibrous tissue usually enhances less but cannot always be differentiated from tumor on CT or MRI.[1,3]

Consecutive studies are extremely helpful: With time, tumor grows (or occasionally remains stable), but scar tissue tends to contract and, thus, decrease in size. In the absence of prior studies for comparison, a CT- or MRI-guided biopsy of the abnormal soft tissue may provide the diagnosis (Figure 6).

Bone and Cartilage

FIGURE 6
CT-Guided Biopsy CT-Guided Biopsy
FIGURE 7
Coronal CT (bone algorithm) Coronal CT (bone algorithm)

Tumor has a very different density (on CT) and signal intensity (on MRI) than cortical bone.[3,4] Cortical bone is a dense white line on CT (Figure 7). Its density is much greater than that of tumor, making CT an ideal modality for the evaluation of erosion of bone.

Bone algorithms can be created from the initial CT scan data to emphasize bone detail. Even subtle erosion of thin cortical bone, such as tegmen tympani (Figure 7), cribriform plate, and lamina papyracea, is easily detected on CT bone algorithms.

On MRI, cortical bone is a signal void. This is a very different signal intensity from tumor, but subtle erosion of a signal void is difficult to detect, making MRI less useful than CT for evaluating cortical bone erosion by tumor.

In contrast, MRI is an excellent imaging modality for the evaluation of medullary bone and bone marrow.[5] In adults, marrow signal in the head and neck is mostly attributable to fat. Recruitment of fatty or yellow marrow for hematopoiesis, as well as fibrosis of marrow, alters this signal.[6] When hypointense tumor invades marrow, the different signals are easily seen on nonenhanced T1-weighted images. Because some tumors enhance intensely after IV gadolinium contrast administration, tumor may become isointense to marrow after gadolinium. Fat-suppression pulse sequences are special image acquisitions that decrease the high signal of fat without altering the high signal of enhancing tumor. Nasopharyngeal squamous cell carcinoma invading the clivus and oral cavity squamous cell carcinoma invading the mandible are two settings in which the extent of tumor invasion of the marrow can determine the extent of resection, or determine whether it is possible at all.[4]

The appearance of the cartilage of the normal adult larynx is quite variable.[5] Cartilage may mineralize and even ossify. Mineralized laryngeal cartilage is dense (white) on CT and hypointense on MRI. Ossified laryngeal cartilage has a cortex and marrow-containing medullary cavity (Figure 8a and Figure 8b).

FIGURE 8A
Computed tomography (soft-tissue algorithm) shows an abnormally bulky right false vocal cord containing tumor (T); compare to the normal left side (large arrowheads). The thyroid cartilage adjacent to the tumor is ossified but discontinuous (small arrowheads); it is impossible to determine whether the discontinuity is a normal variant or represents tumor erosion. Computed tomography (soft-tissue algorithm) shows an abnormally bulky right false vocal cord containing tumor (T); compare to the normal left side (large arrowheads). The thyroid cartilage adjacent to the tumor is ossified but discontinuous (small arrowheads); it is impossible to determine whether the discontinuity is a normal variant or represents tumor erosion.
FIGURE 8B
Magnetic resonance imaging (T1-weighted, gadolinium-enhanced, fat-suppressed) shows a left true vocal cord tumor (long arrow). The thyroid cartilage is ossified, and the marrow on the left enhances (open short arrow), indicating tumor or edema from a nearby tumor. The signal intensity of marrow in the right thyroid also is normal (closed short arrow). Magnetic resonance imaging (T1-weighted, gadolinium-enhanced, fat-suppressed) shows a left true vocal cord tumor (long arrow). The thyroid cartilage is ossified, and the marrow on the left enhances (open short arrow), indicating tumor or edema from a nearby tumor. The signal intensity of marrow in the right thyroid also is normal (closed short arrow).

Ideally, CT would be able to detect a squamous cell carcinoma of the true or false vocal cord that erodes the cortex of the ossified thyroid or cricoid cartilage. However, the normal laryngeal cartilage ossifies irregularly and discontinuously; consequently, on CT images, it may be impossible to determine whether a defect in the cartilage is erosion by tumor or a normal discontinuity (Figure 8a). Only if a laryngeal tumor extends to the extralaryngeal surface of the cartilage, invading or displacing strap muscles, can the discontinuity be presumed to be erosion. Magnetic resonance imaging, by contrast, is an ideal imaging modality for evaluating ossified laryngeal cartilage, as even small foci of marrow invasion by tumor are easily seen (Figure 8b).

Marrow edema secondary to tumor may have a similar or identical imaging appearance as the tumor itself. Although this is a potential limitation of imaging, in fact, marrow edema usually reflects tumor invasion nearby.

Fat

Tumor and fat have very different appearances on both CT and MRI studies and are readily distinguished.[1,3,4] On CT, fat is lucent (hypodense, dark) with respect to tumor (Figure 4). In general, only air is more lucent than fat. On T1-weighted MRI sequences, fat is hyperintense (white).

To differentiate tumor from fat on MRI, nonenhanced T1-weighted images are useful. After gadolinium administration, the white of enhancing tumor may blend with the white of normal orbital fat. Fat-suppression techniques darken the high signal of fat without altering the high signal of enhancing tumor (Figure 5), just as with marrow imaging. Both nonenhanced T2-weighted images and fat-suppressed enhanced images are essential to the evaluation of neoplasms that abut fat.

When it is impossible to differentiate tumor from extraocular muscle in the orbit, fat becomes a useful landmark: Identification of an intact fat plane between enhancing tumor and enhancing muscle on all images strongly suggests that the muscle is spared. Effacement of the fat may indicate frank invasion of muscle by tumor, or only tumor compression of fat (Figure 5).

FIGURE 9A
Axial CT (soft-tissue algorithm, contrast-enhanced) shows tumor infiltrating the left pterygopalatine fossa (black arrow). Tumor replaces fat, which normally fills the fossa, as on the normal right side (black arrowhead). Axial CT (soft-tissue algorithm, contrast-enhanced) shows tumor infiltrating the left pterygopalatine fossa (black arrow). Tumor replaces fat, which normally fills the fossa, as on the normal right side (black arrowhead).

As with marrow fat, edema at the periphery of a tumor may infiltrate fat and have an identical appearance to tumor in the fat. Edema secondary to radiation therapy is usually identified more easily as a reticular infiltrate in deep and subcutaneous fat planes.[7] After radiation therapy, this is usually accompanied by thickening of the platysma muscle, intense enhancement of the major salivary glands (eg, the parotids), and low-density thickening (edema) of the aryepiglottic folds.[7]

Cranial Nerves

Cranial nerves exit the skull base surrounded by fat.[8-11] Replacement of this fat, on CT or MRI, by soft tissue strongly suggests perineural extension of tumor along cranial nerves. This is most easily appreciated just beneath the skull base at the neural foramina: stylomastoid foramen for the facial nerve (parotid tumors) and foramen ovale for the mandibular division and fora-men rotundum for the maxillary division of the trigeminal nerve (oral cavity tumors).[11]

On CT (Figure 3 and Figure 9a), perineural tumor causes enlargement and erosion of the skull base foramina and canals that transmit the affected cranial nerves.[8-10] On MRI (Figure 9b), the corresponding abnormalities are intense enhancement and enlargement of the nerves.[11] Magnetic resonance imaging does not show erosion of neural foramina very well. It is likely that MRI shows enhancement earlier than CT shows enlargement or erosion of the bone; therefore, MRI is a more sensitive test for the detection of perineural tumor growth.

Adenoid cystic carcinoma from major and minor salivary glands, squamous cell carcinoma, lymphoma, and melanoma all have a predilection for perineural tumor spread. In patients with these tumors, it is especially important to inspect the path that cranial nerves take to and from the tumor.[11]

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This article reviewed

Commentary (Lanzieri): Current Imaging Techniques for Head and Neck Tumors






 
RELATED CONTENT

Parotid Gland Swelling in 45-Year-Old Patient
May 6, 2013
Status of HPV-Related Cancers and Vaccination Trends
February 21, 2013
A 53-Year-Old Man Presents With Painful Neck Swelling
August 30, 2012
Laryngeal Mass Discovered in 46-Year-Old Man
July 23, 2012
Locoregional Recurrence of an HPV-Positive Squamous Cell Carcinoma of the Head and Neck
ONCOLOGY,  October 12, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Head And Neck Cancer
Evidence on Head And Neck Cancer
Guidelines on Head And Neck Cancer
Patient Education on Head And Neck Cancer
Clinical Trials on Head And Neck Cancer
Practical Articles on Head And Neck Cancer
Research and Reviews on Head And Neck Cancer
All "Head And Neck Cancer" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy